408 related articles for article (PubMed ID: 32534186)
1. Procalcitonin levels in COVID-19 patients.
Hu R; Han C; Pei S; Yin M; Chen X
Int J Antimicrob Agents; 2020 Aug; 56(2):106051. PubMed ID: 32534186
[TBL] [Abstract][Full Text] [Related]
2. Features of severe COVID-19: A systematic review and meta-analysis.
Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
[TBL] [Abstract][Full Text] [Related]
3. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
[No Abstract] [Full Text] [Related]
4. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.
Xu JB; Xu C; Zhang RB; Wu M; Pan CK; Li XJ; Wang Q; Zeng FF; Zhu S
Sci Rep; 2020 Sep; 10(1):15058. PubMed ID: 32929124
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.
Heesom L; Rehnberg L; Nasim-Mohi M; Jackson AIR; Celinski M; Dushianthan A; Cook P; Rivinberg W; Saeed K
J Glob Antimicrob Resist; 2020 Sep; 22():782-784. PubMed ID: 32717489
[No Abstract] [Full Text] [Related]
7. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
[No Abstract] [Full Text] [Related]
8. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
Delgado-Roche L; Mesta F
Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).
Heald-Sargent T; Muller WJ; Zheng X; Rippe J; Patel AB; Kociolek LK
JAMA Pediatr; 2020 Sep; 174(9):902-903. PubMed ID: 32745201
[TBL] [Abstract][Full Text] [Related]
10. Platelet gene expression and function in patients with COVID-19.
Manne BK; Denorme F; Middleton EA; Portier I; Rowley JW; Stubben C; Petrey AC; Tolley ND; Guo L; Cody M; Weyrich AS; Yost CC; Rondina MT; Campbell RA
Blood; 2020 Sep; 136(11):1317-1329. PubMed ID: 32573711
[TBL] [Abstract][Full Text] [Related]
11. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
[TBL] [Abstract][Full Text] [Related]
12. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen L; Liu HG; Liu W; Liu J; Liu K; Shang J; Deng Y; Wei S
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):203-208. PubMed ID: 32164089
[No Abstract] [Full Text] [Related]
14. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.
Berthelot JM; Lioté F
EBioMedicine; 2020 Jun; 56():102801. PubMed ID: 32454408
[No Abstract] [Full Text] [Related]
15. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
[TBL] [Abstract][Full Text] [Related]
16. Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure.
Kodama T; Kouzaki Y; Kawano S; Obinata H; Taniguchi H; Sasaki H; Ota S; Kawana A; Tamura K
J Infect Chemother; 2020 Nov; 26(11):1220-1223. PubMed ID: 32792249
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran.
Abadi MSS; Taheri E; Raesi A; Arjmand MH; Kheirii S; Shahinfard N; Habibi Z
Infect Disord Drug Targets; 2022; 22(3):e070122200097. PubMed ID: 34994319
[TBL] [Abstract][Full Text] [Related]
20. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).
Ciaccio M; Agnello L
Diagnosis (Berl); 2020 Nov; 7(4):365-372. PubMed ID: 32589600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
